159 related articles for article (PubMed ID: 23905706)
1. Introduction: optimal in vitro fertilization in 2020: the global perspective.
Fauser BC; Serour GI
Fertil Steril; 2013 Aug; 100(2):297-8. PubMed ID: 23905706
[TBL] [Abstract][Full Text] [Related]
2. [Multiple pregnancy is the most known risk of fertilization in vitro. Review of the relevant literature].
Bygdeman M
Lakartidningen; 2000 Nov; 97(47):5463-4. PubMed ID: 11192771
[No Abstract] [Full Text] [Related]
3. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
[TBL] [Abstract][Full Text] [Related]
4. Obstetric outcome of women with in vitro fertilization pregnancies hospitalized for ovarian hyperstimulation syndrome: a case-control study.
Courbiere B; Oborski V; Braunstein D; Desparoir A; Noizet A; Gamerre M
Fertil Steril; 2011 Apr; 95(5):1629-32. PubMed ID: 21215968
[TBL] [Abstract][Full Text] [Related]
5. Coasting vs. cryopreservation of all embryos for prevention of ovarian hyperstimulation syndrome in in vitro fertilization.
Huddleston HG; Racowsky C; Jackson KV; Fox JH; Ginsburg ES
Fertil Steril; 2008 Oct; 90(4):1259-62. PubMed ID: 18163999
[TBL] [Abstract][Full Text] [Related]
6. Complications of in vitro fertilization with intracytoplasmic sperm injection in human immunodeficiency virus serodiscordant couples.
Peña JE; Thornton MH; Sauer MV
Arch Gynecol Obstet; 2003 Aug; 268(3):198-201. PubMed ID: 12756584
[TBL] [Abstract][Full Text] [Related]
7. The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles.
Owj M; Tehrani-Nejad ES; Amirchaghmaghi E; Baghestani AR; Ahmadi J
Saudi Med J; 2005 Oct; 26(10):1584-7. PubMed ID: 16228060
[TBL] [Abstract][Full Text] [Related]
8. [Ovarian hyperstimulation syndrome during in vitro fertilization stimulations. Comparison between the experience of the Center for Medically Assisted Procreation of the Saint Antoine maternity department and a review of the literature].
Guettier X; Larue L; Chamorand E; Barbier D; Jault T; Liou Y; Marpeau L; Barrat J
J Gynecol Obstet Biol Reprod (Paris); 1992; 21(8):887-95. PubMed ID: 1491132
[TBL] [Abstract][Full Text] [Related]
9. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection.
Buckett WM; Chian RC; Holzer H; Dean N; Usher R; Tan SL
Obstet Gynecol; 2007 Oct; 110(4):885-91. PubMed ID: 17906024
[TBL] [Abstract][Full Text] [Related]
10. [Immediate complications of in vitro fertilization].
Jokimaa V
Duodecim; 2006; 122(4):434-40. PubMed ID: 16623098
[No Abstract] [Full Text] [Related]
11. Safety of assisted reproduction, assessed by risk of abnormalities in children born after use of in vitro fertilization techniques.
Alukal JP; Lipshultz LI
Nat Clin Pract Urol; 2008 Mar; 5(3):140-50. PubMed ID: 18253110
[TBL] [Abstract][Full Text] [Related]
12. [Assisted reproduction and risks of superovulation].
Seppälä M; Tiitinen A; Teramo K; Raivio K
Duodecim; 1996; 112(4):245-7. PubMed ID: 10590636
[No Abstract] [Full Text] [Related]
13. In vitro fertilization in the polycystic ovary syndrome patient: an update.
Lin K; Coutifaris C
Clin Obstet Gynecol; 2007 Mar; 50(1):268-76. PubMed ID: 17304041
[No Abstract] [Full Text] [Related]
14. [Incidence of ovarian hyperstimulation syndrome in in-vitro-fertilization treatment over a period of 11 years].
Niederberger V; Rottensteiner-Grohsmann C; Turnheim K; Obruca A; Brunner M; Feichtinger W
Wien Med Wochenschr; 1995; 145(23):642-5. PubMed ID: 8578756
[TBL] [Abstract][Full Text] [Related]
15. Ovarian hyperstimulation and the in vitro fertilization procedure do not influence early neuromotor development; a history of subfertility does.
Middelburg KJ; Haadsma ML; Heineman MJ; Bos AF; Hadders-Algra M
Fertil Steril; 2010 Feb; 93(2):544-53. PubMed ID: 19361794
[TBL] [Abstract][Full Text] [Related]
16. [In vitro maturation: the French experience].
Lornage J
J Gynecol Obstet Biol Reprod (Paris); 2006 Sep; 35(5 Pt 2):2S3-2S7. PubMed ID: 17057614
[TBL] [Abstract][Full Text] [Related]
17. Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial.
Palomba S; Falbo A; Carrillo L; Villani MT; Orio F; Russo T; Di Cello A; Cappiello F; Capasso S; Tolino A; Colao A; Mastrantonio P; La Sala GB; Zullo F; Cittadini E;
Fertil Steril; 2011 Dec; 96(6):1384-1390.e4. PubMed ID: 21982727
[TBL] [Abstract][Full Text] [Related]
18. The association of in vitro fertilization and perinatal morbidity.
Kalra SK; Molinaro TA
Semin Reprod Med; 2008 Sep; 26(5):423-35. PubMed ID: 18825610
[TBL] [Abstract][Full Text] [Related]
19. [IVF in Sweden--continuous follow-up of children and mothers].
Finnström O; Nygren NG; Olausson PO
Lakartidningen; 2006 Aug 9-22; 103(32-33):2301-5. PubMed ID: 16955577
[No Abstract] [Full Text] [Related]
20. Ethics and reproductive medicine. Preface.
Sauer MV
Semin Reprod Med; 2010 Jul; 28(4):277-80. PubMed ID: 20694947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
